NCT05607069

Brief Summary

The present study aims to evaluate how commonly diagnostic tools employed in the preoperative evaluation of respiratory function in thoracic surgery can identify pathological alteration due to a previous SARS-CoV-2 infection. In particular, the investigators will gather information concerning imaging (lung ct and lung ultrasound), arterial blood gas analysis, and pulmonary function tests.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 28, 2022

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

November 4, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 7, 2022

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 28, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 28, 2024

Completed
Last Updated

August 2, 2023

Status Verified

July 1, 2023

Enrollment Period

1 year

First QC Date

November 4, 2022

Last Update Submit

August 1, 2023

Conditions

COVID-19 Respiratory Infection

Outcome Measures

Primary Outcomes (1)

  • sensibility of preoperative evaluation in identifying pathological sequelae due to SARS-Cov2 infection

    12 month

Study Arms (1)

COVID-19 previous infection

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study will enroll patients scheduled for lung resection surgery that had a documented previous SARS-Cov2 infection.

You may qualify if:

  • previous SARS-Cov2 infection
  • awaiting lung resection surgery

You may not qualify if:

  • less than 18 years of age
  • unable to consent to enroll
  • refuse to enroll

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AOU Città della Salute e della Scienza di Torino

Turin, 10100, Italy

RECRUITING

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 4, 2022

First Posted

November 7, 2022

Study Start

May 28, 2022

Primary Completion

May 28, 2023

Study Completion

May 28, 2024

Last Updated

August 2, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations

IT(1)